About Us
Markets
Research
Services
NRI Corner
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
+13 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Technicals
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Divident
Right Issues
Split Of Facevalue
Summary
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Profit & Loss
Suven Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:
543064
NSE Symbol:
SUVENPHAR
P/E :
98.31
ISIN Demat:
INE03QK01018
Div & Yield %:
0
EPS :
11.05
Book Value:
86.66
Market Cap (Rs. Cr.):
27,653.39
Face Value :
1
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
1,024.99
1,330.08
1,320.22
1,009.72
833.79
377.83
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,024.99
1,330.08
1,320.22
1,009.72
833.79
377.83
Other Income
55.09
44.55
187.79
14.24
18.12
0.60
Stock Adjustments
-53.88
20.94
60.35
8.37
11.05
21.32
Total Income
1,026.20
1,395.57
1,568.36
1,032.33
862.96
399.75
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
248.38
421.36
459.46
310.32
240.24
124.52
Power & Fuel Cost
46.16
71.35
59.55
44.20
38.24
18.06
Employee Cost
126.88
108.58
100.48
76.23
65.10
29.63
Other Manufacturing Expenses
83.19
101.96
115.25
90.76
66.49
33.83
Selling & Administrative Expenses
38.85
43.57
52.38
44.93
44.72
16.23
Miscellaneous Expenses
17.75
13.50
11.17
8.61
5.26
5.34
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
561.21
760.33
798.29
575.05
460.05
227.60
Operating Profit
465.00
635.24
770.08
457.28
402.91
172.15
Interest
7.43
12.75
8.53
11.66
21.81
2.79
Gross Profit
457.57
622.49
761.55
445.62
381.10
169.36
Depreciation
48.79
43.10
39.10
31.64
23.51
11.50
Profit Before Tax
408.78
579.39
722.45
413.98
357.59
157.86
Tax
97.37
142.45
157.63
101.72
88.81
33.17
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
6.59
4.34
6.72
3.62
-1.30
15.42
Reported Net Profit
304.82
432.60
558.10
308.65
270.08
109.27
Extraordinary Items
32.53
10.55
14.53
2.51
4.73
0.11
Adjusted Net Profit
272.29
422.05
543.57
306.14
265.35
109.16
Adjustment below Net Profit
-0.30
-0.26
-0.76
-0.84
-13.90
315.80
P & L Balance brought forward
1,490.07
1,276.39
835.88
568.52
390.98
0.00
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
218.65
116.83
40.46
78.64
34.09
P & L Balance carried down
1,794.59
1,490.07
1,276.39
835.88
568.52
390.98
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
0.00
600.00
500.00
200.00
500.00
0.00
Dividend Per Share(Rs)
0.00
6.00
5.00
2.00
5.00
0.00
Earnings Per Share-Unit Curr
11.97
16.99
21.92
12.12
21.22
20.60
Earnings Per Share(Adj)-Unit Curr
11.97
16.99
21.92
12.12
10.61
20.60
Book Value-Unit Curr
80.76
68.72
59.74
41.84
61.50
0.00
Book Value(Adj)-Unit Curr
80.76
68.72
59.74
41.84
30.75
0.00